A Comparison of Intramuscular and Subcutaneous Administration of 17-hydroxyprogesterone Caproate (17-OHPC) in Pregnancy
Latest Information Update: 07 Aug 2023
At a glance
- Drugs Hydroxyprogesterone (Primary) ; Hydroxyprogesterone (Primary)
- Indications Preterm birth
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 01 Aug 2023 Status changed from active, no longer recruiting to discontinued. Sponsor stopped study as the study drugs were withdrawn from the market.
- 02 Mar 2023 Planned End Date changed from 31 Jan 2023 to 31 May 2023.
- 02 Mar 2023 Planned primary completion date changed from 31 Jan 2023 to 31 May 2023.